Literature DB >> 24493465

An association between serum γ-glutamyltransferase and proteinuria in drinkers and non-drinkers: a Japanese nationwide cross-sectional survey.

Toshihiro Ishigami1, Ryohei Yamamoto, Yasuyuki Nagasawa, Yoshitaka Isaka, Hiromi Rakugi, Kunitoshi Iseki, Kunihiro Yamagata, Kazuhiko Tsuruya, Hideaki Yoshida, Shouichi Fujimoto, Koichi Asahi, Issei Kurahashi, Yasuo Ohashi, Toshiki Moriyama, Tsuyoshi Watanabe.   

Abstract

BACKGROUND: The association between alcohol consumption and chronic kidney disease (CKD), characterized by reduced glomerular filtration rate and proteinuria, is controversial. Recent studies suggest that serum γ-glutamyltransferase (GGT) level, a conventional marker of excessive alcohol consumption, predicts the CKD incidence. Little information is available on the difference in the clinical impact of alcohol consumption and GGT on proteinuria.
METHODS: The present cross-sectional survey included 332,296 Japanese people aged ≥40 years in 2008. To examine the associations of GGT and alcohol consumption with proteinuria, 134,600 men and 197,696 women were classified into 20 categories based on GGT quartiles and alcohol consumption categories, and their prevalence rate ratios (PRR) of proteinuria defined as ≥1+ of dipstick urinary protein were calculated after adjusting for clinically relevant factors.
RESULTS: Prevalence of proteinuria was 7.5 and 3.7 % in men and women, respectively. In both gender an association between alcohol consumption and proteinuria was in a J-shaped fashion with the lowest PRR of mild drinkers with ≤19 g/day of ethanol consumption, whereas an association between serum GGT level and proteinuria was linear. Compared with rare drinkers in the lowest GGT quartile, the subjects in higher GGT quartiles had a higher probability of proteinuria, irrespective of alcohol consumption. An optimal cutoff level of serum GGT was 43.6 and 23.2 IU/L in men and women, respectively.
CONCLUSIONS: The subjects with higher serum GGT level had a higher probability of proteinuria, regardless of alcohol consumption, suggesting that GGT has a clinically greater impact on CKD than alcohol consumption.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24493465     DOI: 10.1007/s10157-014-0938-5

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  73 in total

Review 1.  The role of genetic polymorphisms in alcoholic liver disease.

Authors:  Felix Stickel; Christoph H Osterreicher
Journal:  Alcohol Alcohol       Date:  2006-02-21       Impact factor: 2.826

2.  Relationship between response of gamma-glutamyltransferase to alcohol consumption and levels of fasting plasma glucose.

Authors:  Yoshiaki Hashimoto; Azusa Futamura
Journal:  Diabetes Res Clin Pract       Date:  2008-03-14       Impact factor: 5.602

3.  Alcohol and kidney damage: a Janus-faced relationship.

Authors:  Elke Schaeffner; Eberhard Ritz
Journal:  Kidney Int       Date:  2012-02-29       Impact factor: 10.612

4.  Risk factor profiles based on estimated glomerular filtration rate and dipstick proteinuria among participants of the Specific Health Check and Guidance System in Japan 2008.

Authors:  Kunitoshi Iseki; Koichi Asahi; Toshiki Moriyama; Kunihiro Yamagata; Kazuhiko Tsuruya; Hideaki Yoshida; Shoichi Fujimoto; Tsuneo Konta; Issei Kurahashi; Yasuo Ohashi; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2011-11-08       Impact factor: 2.801

Review 5.  Alcohol consumption and type 2 diabetes Meta-analysis of epidemiological studies indicates a U-shaped relationship.

Authors:  S Carlsson; N Hammar; V Grill
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

Review 6.  Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies.

Authors:  Lando L J Koppes; Jacqueline M Dekker; Henk F J Hendriks; Lex M Bouter; Robert J Heine
Journal:  Diabetes Care       Date:  2005-03       Impact factor: 19.112

7.  Association of genetic polymorphisms in ADH and ALDH2 with risk of coronary artery disease and myocardial infarction: a meta-analysis.

Authors:  Hongguang Han; Huishan Wang; Zongtao Yin; Hui Jiang; Minhua Fang; Jingsong Han
Journal:  Gene       Date:  2013-05-16       Impact factor: 3.688

Review 8.  Is serum gamma glutamyltransferase a marker of oxidative stress?

Authors:  Duk-Hee Lee; Rune Blomhoff; David R Jacobs
Journal:  Free Radic Res       Date:  2004-06

9.  A combination of healthy lifestyle factors is associated with a decreased incidence of chronic kidney disease: a population-based cohort study.

Authors:  Minako Wakasugi; Junichiro J Kazama; Suguru Yamamoto; Kazuko Kawamura; Ichiei Narita
Journal:  Hypertens Res       Date:  2012-11-22       Impact factor: 3.872

10.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

View more
  3 in total

1.  Association between serum γ-glutamyltransferase and chronic kidney disease in urban Han Chinese: a prospective cohort study.

Authors:  Zhen-Wei Shen; Jie Xing; Qing-Lian Wang; Ali Faheem; Xiang Ji; Jie Li; Wei-Wei Bian; Zheng Jiang; Xiu-Jun Li; Fu-Zhong Xue; Jing Liu
Journal:  Int Urol Nephrol       Date:  2016-10-04       Impact factor: 2.370

2.  Burden of Proteinuria and Risk Factors of Chronic Kidney Disease among Adult Population in Urban Puducherry, India.

Authors:  Manan Jhawar; Venkatachalam Jayaseelan; Ramya Selvaraj
Journal:  J Clin Diagn Res       Date:  2017-08-01

3.  Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study.

Authors:  Masashi Okamoto; Teruki Miyake; Kohichiro Kitai; Shinya Furukawa; Shin Yamamoto; Hidenori Senba; Sayaka Kanzaki; Akiko Deguchi; Mitsuhito Koizumi; Toru Ishihara; Hiroaki Miyaoka; Osamu Yoshida; Masashi Hirooka; Teru Kumagi; Masanori Abe; Bunzo Matsuura; Yoichi Hiasa
Journal:  PLoS One       Date:  2018-04-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.